BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24

• Press Releases

  MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies

  August 19, 2026

   · 

  2 min read
• Press Releases

  Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

  August 19, 2026

   · 

  19 min read
• Press Releases

  AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®

  August 19, 2026

   · 

  9 min read
• Press Releases

  Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026

  August 19, 2026

   · 

  7 min read
• Press Releases

  Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results

  August 19, 2026

   · 

  7 min read
• Press Releases

  Atsena Therapeutics Appoints Matt Pauls to Board of Directors

  August 19, 2026

   · 

  4 min read
• Press Releases

  PICI Invests More Than $1 Million in Five Early Career Researchers Advancing the Future of Cancer Immunotherapy

  August 19, 2026

   · 

  5 min read
• Press Releases

  /C O R R E C T I O N -- Vector Sciences & Therapeutics/

  August 19, 2026

   · 

  5 min read
• Press Releases

  Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum

  August 19, 2026

   · 

  3 min read
• Press Releases

  Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech to Advance Programs Targeting Thymic Function and Immune Resilience

  August 19, 2026

   · 

  4 min read